272
Participants
Start Date
March 31, 2015
Primary Completion Date
August 31, 2019
Study Completion Date
September 30, 2024
Fantom Sirolimus-Eluting Coronary Bioresorbable Scaffold
Bioresorbable Drug-Eluting Scaffold Implantation for the Treatment of Coronary Artery Disease
The Prince Charles Hospital, Chermside
St Vincent's Hospital Sydney, Darlinghurst
Prince of Wales Hospital (Eastern Heart), Randwick
Cardiovascular Center Aalst, Aalst
Albert Einstein Hospital, São Paulo
Instituto Dante Pazzanese de Cardiologia, São Paulo
Aarhus University Hospital (Skejby), Aarhus
Rigshospitalet, Copenhagen
Odense University Hospital, Odense
institut Hospitalier J.Cartier, Massy
La Pitié-Salpétrière, Paris
Clinique Pasteur, Toulouse
Hôpital Rangueil, Toulouse
Am Urban Hospital, Berlin, Berlin
Friedrichshein Hospital, Berlin, Berlin
Klinikum Coburg, Coburg
St.- Johannes-Hospital Dortmund, Dortmund
Universitätsklinikum Erlangen, Erlangen
Elisabeth-Krankenhaus Essen, Essen
Universitätsklinikum Schleswig-Holstein, Kiel
Academic Medical Center Amsterdam, Amsterdam
Onze Lieve Vrouwe Gasthuis, Amsterdam
Erasmus Medical Center, Rotterdam
University Medical Center Utrecht, Utrecht
Krakowskie Centrum Kardiologii Inwazyjnej, Krakow
Szpital Uniwersytecki w Krakowie, Krakow
Szpital Kliniczny Przemienienia Panskiego UM w Poznaniu, Poznan
Oddział Kardiologii Inwazyjnej I Katedra, Warsaw
REVA Medical, Inc.
INDUSTRY